Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06918977 · ClinicalTrials.gov registry record · NA

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

A NA study of Diabetes Mellitus, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
2
Study locations

NCT06918977 is a NA study of Diabetes Mellitus that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 50 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06918977, a NA study of Diabetes Mellitus, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insulin pens, CGMs and telemedicine, leading to improved blood sugar control and better clinical outcomes.

Conditions Studied

Interventions

  • DEVICE InPen Smart insulin pen
  • OTHER traditional/standard insulin pen

Study Locations (2)

Maryland

  • Baltimore VA Maryland Center - Baltimore
  • VAMHCS, Diabetes Outpatient Clinic - Baltimore

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-01-30
Est. Completion 2028-05-30
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT06918977

The ClinicalTrials.gov registry entry for NCT06918977 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which InPen Smart insulin pen is the first listed.

NCT06918977 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06918977 about?

NCT06918977 is a clinical study titled "Improving Glycemic Control With Telemedicine and Smart Insulin Pens". Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insuli...

What is the current status of trial NCT06918977?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-01-30. Estimated completion is 2028-05-30.

What conditions does trial NCT06918977 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT06918977?

The interventions under investigation include: InPen Smart insulin pen (DEVICE), traditional/standard insulin pen (OTHER).

Who is sponsoring clinical trial NCT06918977?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06918977 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.